{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:24:10Z","timestamp":1740173050507,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40618-020-01443-x","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T05:02:33Z","timestamp":1602133353000},"page":"1543-1546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Age-related differences of immune infiltrates in pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-9682","authenticated-orcid":false,"given":"S.","family":"Batchu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"1443_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ncpendmet0396","volume":"3","author":"K Pacak","year":"2007","unstructured":"Pacak K, Eisenhofer G, Ahlman H et al (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 3:92\u2013102","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915\u20131942. https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"1443_CR3","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3747\/co.21.1579","volume":"21","author":"M Lefebvre","year":"2014","unstructured":"Lefebvre M, Foulkes WD (2014) Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol 21:e8\u2013e17","journal-title":"Curr Oncol"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T et al (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol 24:235\u2013251","journal-title":"Adv Anat Pathol"},{"key":"1443_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes RM, Al-Shibli K, Donnem T et al (2011) The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol 6:824\u2013833","journal-title":"J Thorac Oncol"},{"issue":"4","key":"1443_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD et al (2018) (2019) The Immune Landscape of Cancer. Immunity 48(4):812\u2013830.e14 (published correction appears in Immunity. 51(2):411\u2013412)","journal-title":"Immunity"},{"issue":"15","key":"1443_CR7","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-17-3509","volume":"24","author":"D Tamborero","year":"2018","unstructured":"Tamborero D, Rubio-Perez C, Mui\u00f1os F et al (2018) A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations. Clin Cancer Res 24(15):3717\u20133728","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1443_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR et al (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31(2):181\u2013193","journal-title":"Cancer Cell"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL et al (2019) Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 37:773\u2013782","journal-title":"Nat Biotechnol"},{"issue":"9","key":"1443_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/2326-6066.CIR-15-0233","volume":"4","author":"E Porta-Pardo","year":"2016","unstructured":"Porta-Pardo E, Godzik A (2016) Mutation drivers of immunological responses to cancer. Cancer Immunol Res 4(9):789\u2013798","journal-title":"Cancer Immunol Res"},{"issue":"5\u20136","key":"1443_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12672-017-0303-8","volume":"8","author":"J Hadoux","year":"2017","unstructured":"Hadoux J, Terroir M, Leboulleux S et al (2017) Interferon-alpha treatment for disease control in metastatic pheochromocytoma\/paraganglioma patients. Horm Cancer 8(5\u20136):330\u2013337","journal-title":"Horm Cancer"},{"issue":"17","key":"1443_CR12","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1200\/JCO.2002.03.052","volume":"20","author":"JM Kirkwood","year":"2002","unstructured":"Kirkwood JM, Bender C, Agarwala S et al (2002) Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J Clin Oncol 20(17):3703\u20133718","journal-title":"J Clin Oncol"},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fonc.2019.01512","volume":"9","author":"SD Jayasingam","year":"2020","unstructured":"Jayasingam SD, Citartan M, Thang TH, Mat Zin AA, Ang KC, Ch'ng ES (2020) Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol 9:1512","journal-title":"Front Oncol"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue Y, Nishikawa H (2019) Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target? Cancer Sci 110:2080\u20132089","journal-title":"Cancer Sci"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40425-019-0610-4","volume":"7","author":"C Lee","year":"2019","unstructured":"Lee C, Jeong H, Bae Y et al (2019) Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide. J Immunother Cancer 7:147","journal-title":"J Immunother Cancer"},{"key":"1443_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-020-0183-x","author":"RE Tay","year":"2020","unstructured":"Tay RE, Richardson EK, Toh HC (2020) Revisiting the role of CD4+ T cells in cancer immunotherapy\u2014new insights into old paradigms. Cancer Gene Ther. https:\/\/doi.org\/10.1038\/s41417-020-0183-x","journal-title":"Cancer Gene Ther"},{"key":"1443_CR17","first-page":"2707","volume":"19","author":"X Zhao","year":"2019","unstructured":"Zhao X, Lei Y, Li G, Cheng Y, Yang H et al (2019) Integrative analysis of cancer driver genes in prostate adenocarcinoma. Mol Med Rep 19:2707\u20132715","journal-title":"Mol Med Rep"},{"issue":"4","key":"1443_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5808\/GI.2013.11.4.239","volume":"11","author":"N Kim","year":"2013","unstructured":"Kim N, Hong Y, Kwon D, Yoon S (2013) Somatic mutaome profile in human cancer tissues. Genomics Inform 11(4):239\u2013244","journal-title":"Genomics Inform"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01443-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T12:34:49Z","timestamp":1633696489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01443-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01443-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any experiments with human participants performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}